Ranked #7,388 of 8,699 institutional investors
Nan Fung Group Holdings Ltd
Kai Tak, K3
$134M
US stock portfolio at live prices · today −$2.3M (−1.70%)
Live prices, last trade 12:09 PM ET
- Value at quarter end (Q3 2026)
- $150M
- Change from Q2 2026
- +$18.2M (+13.82%)
- Positions
- 24 · 3 new, 1 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$24.6M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesLBRX 18.2%MPLT 10.6%OBX 8.20%EVMN 7.61%PCOR 4.79%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| LBRX LB Pharmaceuticals Inc | 630,657 | $24.4M | 18.2% | Unchanged |
| MPLT MapLight Therapeutics, Inc. | 2,300,328 | $14.2M | 10.6% | Added +137% |
| OBX Obsidian Therapeutics, Inc. | 918,765 | $11.0M | 8.20% | New |
| EVMN Evommune Inc | 1,441,032 | $10.2M | 7.61% | Unchanged |
| PCOR Procore Technologies, Inc. | 88,832 | $6.4M | 4.79% | Added +67% |
| ONC BeOne Medicines AG | 15,722 | $6.2M | 4.63% | Unchanged |
| INCY Incyte Corporation | 53,742 | $6.2M | 4.63% | Unchanged |
| RYTM Rhythm Pharmaceuticals, Inc. | 49,120 | $5.6M | 4.14% | Unchanged |
| NUVB Nuvation Bio Inc. | 1,327,224 | $5.0M | 3.72% | New |
| KYMR Kymera Therapeutics, Inc. | 30,875 | $3.6M | 2.67% | Unchanged |
| RVMD Revolution Medicines, Inc. | 19,253 | $3.1M | 2.32% | Unchanged |
| ARGX argenx SE | 2,800 | $2.6M | 1.96% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 5,672 | $2.2M | 1.64% | Unchanged |
| ACAD Acadia Pharmaceuticals Inc. | 102,984 | $1.8M | 1.34% | Unchanged |
| BRVE Braveheart Bio, Inc. | 81,376 | $1.6M | 1.22% | New |
| CELC Celcuity Inc. | 28,300 | $1.5M | 1.14% | Unchanged |
| INSM Insmed Incorporated | 6,580 | $961K | 0.71% | Unchanged |
| HRMY Harmony Biosciences Holdings, Inc. | 27,049 | $895K | 0.67% | Unchanged |
| ETHA iShares Ethereum Trust ETF | 16,850 | $623K | 0.46% | Unchanged |
| IBIT iShares Bitcoin Trust ETF | 15,968 | $536K | 0.40% | Unchanged |
| RXRX Recursion Pharmaceuticals, Inc. | 181,631 | $461K | 0.34% | Reduced −69% |
| RANI Rani Therapeutics Holdings, Inc. | 493,584 | $274K | 0.20% | Unchanged |
| TRDA Entrada Therapeutics, Inc. | 49,082 | $218K | 0.16% | Unchanged |
| BOLT Bolt Biotherapeutics, Inc. | 5,000 | $25K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| CHYM Chime Financial, Inc. | 21,075 | $643K |